Literature DB >> 33258976

[Register and cohort studies : Overview of the most important data sources at the German Rheumatism Research Center].

Y Meißner1, F Milatz2, J Callhoff2, K Minden2,3, A Regierer2, A Strangfeld2.   

Abstract

Over the past 28 years the German Rheumatism Research Center in Berlin has initiated various epidemiological studies in which data on patients with inflammatory rheumatic diseases are collected nationwide and multicentric. The spectrum ranges from rheumatoid arthritis and spondylarthritis to connective tissue diseases and rheumatic diseases in childhood. Based on the respective scientific question, studies of different types were established. The German National Databases for adults and children annually collect cross-sectional data to map the care of patients. In two inception cohorts, adults with early arthritis and patients with juvenile idiopathic arthritis are investigated from disease onset. The long-term observational cohorts/registries RABBIT, RABBIT-SpA and JuMBO focus on the long-term efficacy and safety of biologic drugs and other targeted treatments. Rhekiss investigates women with inflammatory rheumatic diseases when trying to become pregnant, during pregnancy and postpartum. This article highlights each of these observational studies with its characteristics as well as national and international collaborations.

Entities:  

Keywords:  Epidemiology; Health services research; Inflammatory rheumatic diseases; Observational studies; Pharmacovigilance

Year:  2020        PMID: 33258976     DOI: 10.1007/s00393-020-00906-z

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  2 in total

1.  Implementing an automated monitoring process in a digital, longitudinal observational cohort study.

Authors:  Lisa Lindner; Anja Weiß; Andreas Reich; Siegfried Kindler; Frank Behrens; Jürgen Braun; Joachim Listing; Georg Schett; Joachim Sieper; Anja Strangfeld; Anne C Regierer
Journal:  Arthritis Res Ther       Date:  2021-07-07       Impact factor: 5.156

Review 2.  [Latest findings from the RABBIT register].

Authors:  Yvette Meißner; Anja Strangfeld
Journal:  Z Rheumatol       Date:  2021-12-23       Impact factor: 1.530

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.